2023 Cardiovascular Nursing Symposium – General Sessions

Recorded sessions from PCNA's annual Cardiovascular Nursing Symposium

Member Cost: $35Non-member Cost: $75
Credits: 11.75 CE contact hours, 2.0 CE pharmacology hours

Course Overview

Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in cardiology and primary care settings. PCNA develops an annual CE program to meet these clinicians’ clinical practice and recertification needs.

This 2023 curriculum includes a comprehensive approach to cardiovascular risk assessment and treatment in:

  •  Evaluating Chest Pain: Cardiac vs. Non-Cardiac
  • Heart Failure Prevention and Treatment: Latest Guidelines
  • The Role of LP(a) in CVD Risk
  • Kidney Health Equity
  • Behavioral Interventions: Impact on Cardiovascular Risk Factors
  • Structural Heart Interventions: What’s New?
  • CVD Diagnostics: Demystifying which, when and why?
  • Rare Arrhythmias: Do you know what to look for?
  • Mobilizing Nurses to Reduce Hypertension Burden
  • Hypertrophic Cardiomyopathy: Comparing Traditional & Novel Treatments
  • Reflecting on Well-Being: Focus on the Health of Nurses

Member Cost: $35Non-member Cost: $75
Credits: 11.75 CE contact hours, 2.0 CE pharmacology hours

Register

Learning Objectives

  • Evaluating Chest Pain: Cardiac vs. Non-Cardiac
    • Review updated chest pain guidelines
    • Discuss assessment and treatment of non-coronary chest pain
    • Discuss assessment and treatment of coronary chest pain
    • Explain the importance of shared-decision making in clinically stable patients
  • Heart Failure Prevention and Treatment: Latest Guidelines
    • Review HF demographics including impact of SDOH
    • Examine guideline updates for clinical practice
    • Discuss diagnosis, imaging and the new classifications of HF
    • Explain the CV nurse’s role in the prevention of heart failure
  • The Role of LP(a) in CVD Risk
    • Define LP(a)s role in CVD risk
    • Examine current research in lowering LP(a)
    • Explore diagnostic testing to confirm LP(a) diagnosis
    • Discuss treatment options for patients with LP(a) diagnosis
  • Kidney Health Equity
    • Review national data on kidney health disparities
    • Discuss the influence of the inequitable distribution of social determinants of health on kidney outcomes
    • Highlight interventions and policy changes aimed at addressing kidney health disparities
  • Behavioral Interventions: Impact on Cardiovascular Risk Factors
    • Describe the prevalence of mental health issues in cardiac populations
    • Summarize the associations between mental health issues and cardiovascular outcomes, including hypothesized mechanisms
    • Describe best practices for screening and referral for mental health treatment
  • Structural Heart Interventions: What’s New?
    • Define structural heart conditions including valvular disease such as aortic stenosis and mitral regurgitation
    • Review valvular heart disease treatment options including surgery and transcatheter valve options
    • Review procedural heart interventions including TAVR, TMVR, and TEER
    • Explain when to refer to a structural heart program including highlight on social determinants of health
  • CVD Diagnostics: Demystifying which, when and why?
    • Define common CVD diagnostic tests
    • Discuss which tests are appropriate for differing patient complaints
    • Explain test result interpretation and importance of team-based care
    • Explore best practices for next steps and follow up
  • Rare Arrythmias: Do you know what to look for?
    • Review key components of rhythm identification
    • Review pathophysiology and underlying causes of lethal ventricular arrhythmias including Brugada syndrome and Prolonged QT syndrome, wide QRS
    • Review pathophysiology and underlying causes of atrial arrhythmias including Atrial Fibrillation, A Flutter, Wolf Parksinsons White syndrome, SVT
    • Review the team-based approach to diagnosis, treatment and referral pathways
  • Mobilizing Nurses to Reduce Hypertension Burden
    • Describe HTN in population health including disparities
    • Review HTN policies
    • Explain community-based initiatives for hypertension management
    • Discuss the unique role that nurses play
  • Hypertrophic Cardiomyopathy: Comparing Traditional & Novel Treatments
    • Define and diagnose Hypertrophic Cardiomyopathy including non-obstructive and obstructive
    • Describe the journey of a HCM patient using a case study approach
    • Review traditional treatment, pharmacological and lifestyle modifications, for HCM
    • Explore novel pharmacological treatment including mechanism of action of cardiac myosin inhibitors
  • Reflecting on Well-Being: Focus on the Health of Nurses
    • Discuss importance of well-being and self-care
    • Examine a well-being program from implemenation to sustainability
    • Review techniques including work-life balance, joy, mood, resiliency and more
    • Explain importance of sense of community/belonging

CE certificate is available upon successful completion of the post-test and program evaluation.

Faculty

  • Debabrata Mukherjee MD, FACC, FAHA, FSCAI
  • Nancy Albert, MD
  • Keith Ferdinand MD, FACC, FAHA, FASH, FNLA
  • Flor Alvarado MD, MHS MPH
  • Valerie Hoover PhD
  • Kimberly Guibone DNP, ACNP-BC, FACC
  • Abhinav Saxena, MD
  • Dan Sorajja, MD, FACC, FHRS
  • Janet Wright, MD, FACC
  • Heidi Salisbury RN, MSN, CNS-BC, ACGN
  • Keith Jones, MA, BS
Full_Color_Provider

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.